Literature DB >> 28958564

Characterization of lipids in three species of sea urchin.

Xin Zhou1, Da-Yong Zhou2, Ting Lu1, Zhong-Yuan Liu1, Qi Zhao3, Yu-Xin Liu1, Xiao-Pei Hu4, Jiang-Hua Zhang5, Fereidoon Shahidi6.   

Abstract

Sea urchin gonad has been regarded as a "healthy" food. Although previous studies have suggested that sea urchin gonad might serve as a potential rich source of long chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFA) enriched phospholipid (PL), the molecular species profile of its PL has rarely been reported. In this study, about 200 molecular species of glycerophospholipid (GP), including glycerophosphocholine, glycerophosphoethanolamine, glycerophosphoserine, glycerophosphoinositol, lysoglycerophosphocholine and lysoglycerophosphoethanolamine, in gonads from three species of sea urchin (Glyptocidaris crenularis, Strongylocentrotus intermedius and Strongylocentrotus nudus) were characterized using tandem mass spectrometry. Most of the predominant GP molecular species contained PUFA, especially eicosapentaenoic acid (EPA). Meanwhile, the sea urchin lipids contained a high proportion of PL (39.45-50.30% of total lipids) and PUFA (34.47-46.56% of total FA). Among PL, phosphatidylcholine (67.88-72.58mol%) was dominant. Considering the high level of PUFA enriched GP, sea urchin gonads provide great potential as health-promoting food for human consumption.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HPLC-ESI-MS/MS; Lipid class composition; Molecular species; Phospholipid class composition; Sea urchin

Mesh:

Substances:

Year:  2017        PMID: 28958564     DOI: 10.1016/j.foodchem.2017.08.076

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  2 in total

1.  Integrated metabolomic and transcriptomic analyses identify critical genes in eicosapentaenoic acid biosynthesis and metabolism in the sea urchin Strongylocentrotus intermedius.

Authors:  Heng Wang; Jun Ding; Siyu Ding; Yaqing Chang
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

Review 2.  Recent Advancements and Future Perspectives of Microalgae-Derived Pharmaceuticals.

Authors:  Donghua Xia; Wen Qiu; Xianxian Wang; Junying Liu
Journal:  Mar Drugs       Date:  2021-12-12       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.